Related Experiment Video
Updated: Jan 9, 2026
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Why an Antibiotic That is Effective Against a Type of Bacteria May Not Work Better Than "Placebo" in a Randomized
1Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Kansas, Wichita, KS.
Abstract:
"Placebo" is a short-handed way of summarizing good clinical management, or treatment as usual (TAU). While the media and others sometimes equate a placebo with a "sugar pill," by which they mean nothing, the placebo arm in a double-blind randomized controlled trial (RCT) is instead all the treatment received in such a trial except for the investigational treatment. For that reason, an antibiotic effective against bacteria causing an infection may not do better than TAU in an RCT depending on the specific conditions of the infection that the patient has. This finding is important to consider when evaluating the results of RCTs in psychiatric drug development.
Insights
Placebos in clinical trials represent treatment as usual (TAU), not inert substances. Understanding this is crucial for accurately evaluating psychiatric drug development results from randomized controlled trials (RCTs).
Area of Science:
- Clinical research methodology
- Psychiatric drug development
- Evidence-based medicine
Background:
- The term "placebo" is often misunderstood as an inert substance.
- In double-blind randomized controlled trials (RCTs), the placebo arm represents "treatment as usual" (TAU).
- TAU includes all care received except the investigational treatment.
Purpose of the Study:
- To clarify the definition and role of placebos in clinical trials.
- To emphasize the significance of TAU in evaluating investigational treatments.
- To inform the interpretation of RCT results in psychiatric drug development.
Main Methods:
- Conceptual analysis of placebo definition in RCTs.
- Comparison of placebo arm with "sugar pill" misconception.
- Discussion of TAU's impact on trial outcomes.
Main Results:
- Placebos in RCTs are not "sugar pills" but represent comprehensive TAU.
- Effective treatments may not outperform TAU under specific conditions.
- This distinction is critical for interpreting trial data.
Conclusions:
- Accurate understanding of placebos as TAU is essential for evaluating psychiatric drug efficacy.
- Misinterpretation can lead to flawed conclusions in drug development.
- Consideration of TAU is vital when assessing RCT outcomes.
Related Concept Videos
01:54The Placebo Effect
00:57Antibiotic Selection
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
01:30Development of Antibiotic Resistance
01:26Psychosis: Goals of Pharmacotherapy